Log in
Enquire now
‌

US Patent 8252905 Anti-CD14 antibody fusion protein

Patent 8252905 was granted and assigned to Mochida Pharmaceutical on August, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Mochida Pharmaceutical
0
Date Filed
June 5, 2006
0
Date of Patent
August 28, 2012
0
Patent Application Number
11791888
0
Patent Citations Received
‌
US Patent 11965017 Serpin fusion polypeptides and methods of use thereof
0
‌
US Patent 11754566 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
‌
US Patent 11761967 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Patent Inventor Names
Yoshitaka Hosaka
0
Shoji Furusako
0
Takashi Takeuchi
0
Tetsushi Kawahara
0
Kazuyuki Nakayama
0
Masaki Nakamura
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8252905
0
Patent Primary Examiner
‌
Sharon Wen
0

Find more entities like US Patent 8252905 Anti-CD14 antibody fusion protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.